USE OF 4-(4-FLUORO-2-METHOXYPHENYL)-N-{3-[(S-METHYLSULFONIMIDOYL)METHYL]PHENYL}-1,3,5-TRIAZIN-2-AMINE FOR TREATING LEUKEMIAS - Patent 3244894

(19)

(11)

EP 3 244 894 A1

(12)

(43)	Date of publication:
	22.11.2017 Bulletin 2017/47

(21)	Application number: 16700183.3

(22)	Date of filing: 08.01.2016

(51)

International Patent Classification (IPC):

A61K 31/53^(2006.01)
A61K 45/06^(2006.01)

A61P 35/02^(2006.01)

(86)	International application number:
	PCT/EP2016/050251

(87)	International publication number:
	WO 2016/113187 (21.07.2016 Gazette 2016/29)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	MA MD

(30)

Priority:

13.01.2015 EP 15150940

(71)	Applicant: Bayer Pharma Aktiengesellschaft
	13353 Berlin (DE)

(72)	Inventor:
	SCHOLZ, Arne 10435 Berlin (DE)

(74)	Representative: BIP Patents
	c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 10 40789 Monheim am Rhein 40789 Monheim am Rhein (DE)

(54)	USE OF 4-(4-FLUORO-2-METHOXYPHENYL)-N-{3-[(S-METHYLSULFONIMIDOYL)METHYL]PHENYL}-1,3,5-TRIAZIN-2-AMINE FOR TREATING LEUKEMIAS